Ondansetron Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 4 mg, 8 mg
Reference Brands: Zofran(US & EU)
Category: Medical Aid
Ondansetron tablets are 5-HT3 receptor antagonists that block serotonin receptors in the gastrointestinal tract and brain, preventing nausea and vomiting. They are commonly used during chemotherapy, radiation, or postoperative care, providing effective relief from nausea, improving patient comfort, and preventing dehydration and fatigue associated with vomiting. Ondansetron tablets is available in Tablet and strengths such as 4 mg, 8 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ondansetron tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Ondansetron tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Ondansetron tablets are approved in both the US and EU, supported by comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. In the US, Zofran (by GlaxoSmithKline) is a widely used branded product, while in the EU, ondansetron is available as both branded and generic formulations. Regulatory approval involves rigorous clinical and safety evaluations, and detailed dossiers ensure product quality. For more information on licensing, approved dossiers, and regulatory requirements for ondansetron tablets, visit Pharmatradz. Stay informed on the latest approval processes and market access regulations for ondansetron worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Lofexidine Hydrochloride
Strength:
0.18 mg
Form: Tablets
Reference Brands: Lucemyra (USA)
View DetailsMaralixibat
Strength:
380 µg/mL
Form: Oral Solution
Reference Brands: Livmarli (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers